abstract |
The invention relates to medicaments which include 1-cyclopropyl-7- ([[S, S] -2,8-diazabicyclo [4.3.3] non-8-yl) -6-fluoro-1,4-dihydro -8-methoxy -4-oxo-3-quinolonecarboxylic acid and / or its pharmaceutically acceptable salts, and / or linear hydrates as the active ingredient which is released at a certain rate. |